Literature DB >> 26424155

Sleep and agitation in nursing home residents with and without dementia.

Donnamay T Brown1, Juanita L Westbury2, Benjamin Schüz1.   

Abstract

BACKGROUND: The prevalence of dementia in Australian nursing homes is high. A large proportion of residents express themselves through agitated behaviors, with substantial interpersonal and day-to-day variance. One factor that may increase agitation is poor sleep. The current study aimed to determine if sleep influences symptoms of agitation in nursing home residents, and whether this effect differed by dementia status. As benzodiazepines are used widely as hypnotic medication, their impact was also considered.
METHODS: Actigraph devices worn on residents' non-dominant wrists for three days were used to obtain objective measures of sleep. Symptoms of agitation were assessed using staff responses to two standardized questionnaires - the Cohen-Mansfield Agitation Inventory (CMAI) and the Neuropsychiatric Inventory - nursing home version (NPI-NH). Presence of dementia and benzodiazepine use were obtained from resident medical charts.
RESULTS: Forty-nine residents (mean age: 85.57 years) from four nursing homes in Tasmania were included in the study. Results indicated that residents were in bed for an average of 11.04 h and slept for 10.14 h per day. Significant relationships between sleep and verbal as well as non-aggressive agitation were found. No relationships between sleep and aggressive agitation were detected. A significant moderation effect of dementia was found, in which residents without dementia expressed verbal agitation when obtaining less sleep, but not residents with dementia. Benzodiazepine use did not result in significantly more sleep.
CONCLUSIONS: These results suggest that sleep could play an important role in explaining agitation, but more research is needed to explore the relationship between sleep and benzodiazepines in nursing home residents.

Entities:  

Keywords:  aged care; agitation; dementia; nursing homes; sleep

Mesh:

Substances:

Year:  2015        PMID: 26424155     DOI: 10.1017/S1041610215001568

Source DB:  PubMed          Journal:  Int Psychogeriatr        ISSN: 1041-6102            Impact factor:   3.878


  7 in total

Review 1.  Sleep and Long-Term Care.

Authors:  Lichuan Ye; Kathy C Richards
Journal:  Sleep Med Clin       Date:  2017-11-22

2.  Ambient bright light treatment improved proxy-rated sleep but not sleep measured by actigraphy in nursing home patients with dementia: a placebo-controlled randomised trial.

Authors:  Gunnhild J Hjetland; Eirin Kolberg; Ståle Pallesen; Eirunn Thun; Inger Hilde Nordhus; Bjørn Bjorvatn; Elisabeth Flo-Groeneboom
Journal:  BMC Geriatr       Date:  2021-05-17       Impact factor: 3.921

3.  Comorbid Dementia and Cancer in Residents of Nursing Homes: Secondary Analyses of a Cross-Sectional Study.

Authors:  Kjersti Marie Blytt; Geir Selbæk; Jorunn Drageset; Gerd Karin Natvig; Bettina S Husebo
Journal:  Cancer Nurs       Date:  2018 Mar/Apr       Impact factor: 2.592

4.  Measuring the prevalence of sleep disturbances in people with dementia living in care homes: a systematic review and meta-analysis.

Authors:  Lucy Webster; Sergi Costafreda Gonzalez; Aisling Stringer; Amy Lineham; Jessica Budgett; Simon Kyle; Julie Barber; Gill Livingston
Journal:  Sleep       Date:  2020-04-15       Impact factor: 5.849

5.  Evaluation of Wearable Technology in Dementia: A Systematic Review and Meta-Analysis.

Authors:  Alanna C Cote; Riley J Phelps; Nina Shaafi Kabiri; Jaspreet S Bhangu; Kevin Kip Thomas
Journal:  Front Med (Lausanne)       Date:  2021-01-11

Review 6.  Wrist accelerometry for monitoring dementia agitation behaviour in clinical settings: A scoping review.

Authors:  James Chung-Wai Cheung; Bryan Pak-Hei So; Ken Hok Man Ho; Duo Wai-Chi Wong; Alan Hiu-Fung Lam; Daphne Sze Ki Cheung
Journal:  Front Psychiatry       Date:  2022-09-16       Impact factor: 5.435

7.  Clinically significant discrepancies between sleep problems assessed by standard clinical tools and actigraphy.

Authors:  Kjersti Marie Blytt; Bjørn Bjorvatn; Bettina Husebo; Elisabeth Flo
Journal:  BMC Geriatr       Date:  2017-10-27       Impact factor: 3.921

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.